Tools For Action: HIV/AIDS Treatment Access Advocacy Series.
*The following nine workshops are currently available:
Advocacy Level One: Tools and Techniques (.pdf)
This first workshop introduces various types and principles of advocacy. It
presents the six key steps of an action plan: 1) identifying issues, 2)
understanding the issues and defining the goals, 3) developing
strategies, 4) implementing of plan, 5) evaluating the results, and
finally, 6) planning for future steps. The workshop focuses on the
first two steps of the six steps outlined above. Participants finish up
the workshop by applying these two first steps to a lipodystrophy case
study.
Advocacy Level Two: Tools and Strategies (.pdf)
This second advocacy workshop begins with a review of the first module.
Participants then build on what was learned in the initial workshop,
and then advance to the third and fourth steps essential for any action
plan: developing strategies, implementing of plan. Just as in Level
One, the lipodystrophy case study continues as an example.
Advocacy Level Three: Strategies and Action (.pdf)
Level Three begins with a review of the concepts and strategies discussed
during Level 1 and Level 2 in order to move on to the final steps of
evaluating the results, and planning for future steps. Once again, the
lipodystrophy case study is used as the vehicle to work the final two
steps in the group setting.
Women and Access to Treatment – part 1(.pdf)
The first workshop on women’s issues begins with an overview of how
HIV/AIDS specifically affects women in Canada. Participants then look
more in depth at specific issues facing women with regard to diagnosis
of HIV, disclosure, relationships with caregivers, and access to the
various diagnostic and other tests used for HIV/AIDS.
Women and Access to Treatment – part 2(.pdf)
This second and last workshop on women’s issues takes a deeper look at
gender specific issues that create barriers to HIV/AIDS treatment for
women. It then examines the lipid abnormalities issues in women, and
those raised by research carried out or not on them.
First Nations, Inuit and Treatment Access Issues(.pdf)
This workshop first begins by looking at the different Aboriginal
populations in Canada. Participants then examine the principle
challenges and issues regarding access to treatment for Canada’s
Aboriginal populations. It also looks at drug and health care benefits
for these populations.
The Federal Overview (.pdf)
The Federal Overview workshop is designed to pull apart the various roles
the Federal Government plays in treatment access issues. What is the
Federal Government exclusively responsible for, and how does this
affect our access to treatment? This workshop will help participants
identify whom within the Federal Government deals with the various
aspects of HIV/AIDS treatment. The Federal Overview workshop will help
identify whom to contact within these government departments to address
specific issues.
Introduction to Research Ethics in Clinical Trials (.pdf)
This workshop is an introduction to the principles of research ethics, as
defined in two key policy documents, and an exploration of how these
principles play out in the real world. It should allow participants to
discuss how these principles are applied to HIV clinical trials and
what are the main obstacles to free and informed consent.
Post-Approval Surveillance Systems (.pdf)
This workshop familiarises participants with the current surveillance
systems which are tracking the adverse effects of marketed drugs. Its
specific objectives are:
1. To define basic concepts and terms related to drug surveillance,
2. To outline the current Canadian post-approval surveillance system (PASS) and its shortcomings,
3. To briefly describe CTAC’s PASS Study,
4. To discuss as a group the next steps for action.
¤¤¤¤¤
The following workshop are currently in development:
Provincial and Territorial Treatment Access Issues
Prisoners and Access to Treatment
IDUs and Access to Treatment
Persons Co-infected with Hep C and Access to Treatment